全身性および部分性脂肪萎縮症の診断および管理に関する臨床ガイドライン：ギリシャ内分泌学会によって支持された立場表明

LAMBADIARI et al. (Sun,) はこの問題を研究しました。

www.synapsesocial.com/papers/69a7618ec6e9836116a2f929 — DOI: https://doi.org/10.1016/j.eprac.2026.02.014

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Oral Glucagon-Like Peptide 1 Analog as an Adjuvant Therapy in Generalized Lipodystrophy· 2025 · 1 citations
2. Efficacy of leptin therapy in the different forms of human lipodystrophy· 2009 · 178 citations
3. The Clinical Approach to the Detection of Lipodystrophy an Aace Consensus Statement· 2013 · 120 citations
4. Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy· 2019 · 98 citations
5. Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings· 2021 · 28 citations